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Abstract. The release of granulysin, a 9-kDa cationic
protein, from lysosomal granules of cytotoxic T
lymphocytes and natural killer cells plays an impor-
tant role in host defense against microbial pathogens.
Granulysin is endocytosed by the infected target cell
via lipid rafts and kills subsequently intracellular
bacteria. The mechanism by which granulysin binds
to eukaryotic and prokaryotic cells but lyses only the
latter is not well understood. We have studied the
eﬀect of granulysin on large unilamellar vesicles
(LUVs) and supported bilayers with prokaryotic and
eukaryotic lipid mixtures or model membranes with
various lipid compositions and charges. Binding of
granulysin to bilayers with negative charges, as typi-
cally found in bacteria and lipid rafts of eukaryotic
cells, was shown by immunoblotting. Fluorescence
release assays using LUV revealed an increase in
permeability of prokaryotic, negatively charged and
lipid raft-like bilayers devoid of cholesterol. Changes
in permeability of these bilayers could be correlated to
defects of various sizes penetrating supported bilayers
as shown by atomic force microscopy. Based on these
results, we conclude that granulysin causes defects in
negatively charged cholesterol-free membranes, a
membrane composition typically found in bacteria. In
contrast, granulysin is able to bind to lipid rafts in
eukaryotic cell membranes, where it is taken up by the
endocytotic pathway, leaving the cell intact.
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Introduction
Cytotoxic T lymphocytes (CTLs) and natural killer
(NK) cells contribute to the host defense against
intracellular pathogens by release of cytokines that
activate antimicrobial eﬀector pathways (Flynn et al.,
1993) and lyse infected target cells by induction of
apoptosis (Kaspar et al., 2001; Smyth et al., 2001) or by
exocytosis of cytotoxic proteins, such as perforin and
granulysin, which are stored in lysosomes (Kaufmann,
1999; Pena & Krensky, 1997). Granulysin is expressed
constitutively in NK cells and cytotoxic T cells
and upregulated following antigen-driven activation
(Pena & Krensky, 1997; Stegelmann et al., 2005). It is
released from the cytotoxic granules after cellular
stimulation and is active against a broad range of
intracellular pathogens, such as Listeria monocytoge-
nes, Mycobacterium tuberculosis and Trypanosoma
cruzi (Clayberger & Krensky, 2003; Krensky, 2000;
Stenger et al., 1998; Walch et al., 2005).
Granulysin is a 9-kDa protein and belongs to the
saposin-like protein (SAPLIP) family, which includes
amebapores (Bruhn & Leippe, 1999), NK-lysin
(Liepinsh et al., 1997) and saposins A, B, C and
D (Clayberger & Krensky, 2003; Krensky, 2000;
Morimoto et al., 1988, 1989; O¢Brien & Kishimoto,
1991; Qi & Grabowski, 2001). The family members
are cationic proteins, and they share a particular
polypeptide motif of a ﬁve-helix bundle and highly
conserved cysteine residues that form disulﬁde bonds
(Munford, Sheppard & O¢Hara, 1995), which give the
molecule a stable structure. They interact with a
variety of lipids, especially cholesterol (Vaccaro et al.,
1995) and sphingolipids (Vaccaro et al., 1999).
Comparing the amino acid sequences of the SAPLIP
family members reveals that granulysin has the
highest identity to NK-lysin (43% identity), a porcine
protein with antibacterial activity (Andersson et al.,
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1995). Although the SAPLIP family members have
structural similarities, they have various biological
functions: amebapores are capable of forming ion
channels or pores in lipid membranes (Lynch,
Rosenberg & Gitler, 1982; Young et al., 1982),
saposin A-D modify the membrane to become sub-
strates for enzymes and granulysin and NK-lysin
appear to directly permeabilize bacterial membranes
(Anderson et al., 2003; Krensky, 2000).
Recently, it has been found that granulysin binds
to infected cells via lipid rafts (Walch et al., 2005),
which are specialized membrane microdomains
(Simons & Ikonen, 1997). Lipid rafts consist of
phospholipids and cholesterol in the inner membrane
leaﬂet and sphingomyelin and cholesterol in the outer
membrane leaﬂet, and they are involved in a variety
of cellular functions including endocytosis (Brown &
London, 2000; Cambi et al., 2004; Manes, del Real &
Martinez, 2003). Cholesterol has an important role in
lipid rafts and in lipid bilayers, which usually exist in
an ordered gel phase under the transition temperature
of their lipids. However, cholesterol is able to eradi-
cate the sharp transition between ordered gel phase
and liquid crystalline phase, resulting in a liquid or-
dered phase, where the lipids have a high degree of
lateral mobility as well as tightly packed acyl chains
(Brown & London, 2000; McMullen & McElhaney,
1997; Pralle et al., 2000; Simons & Ikonen, 1997).
The lipid raft-bound granulysin is endocytosed
and transferred via membrane vesicles to early
endosomes and then to phagosomes. Subsequently,
bacteria are killed by granulysin via membranolysis,
whereas binding and intracellular traﬃcking of
granulysin do not harm the target cell (Brown &
London, 2000; Walch et al., 2005). Therefore, one
important feature of granulysin is its ability to dis-
tinguish between prokaryotic and eukaryotic cells,
which diﬀer in the lipid composition of their mem-
branes. A eukaryotic cell membrane consists of cho-
lesterol, sphingomyelin and phospholipids, such as
phosphatidylcholine (PC), phosphatidylethanolamine
(PE), phosphatidylserine (PS) and phosphatidylglyc-
erol (PG), whereas the membrane of a prokaryotic
cell lacks cholesterol and sphingomyelin, consisting
mainly of cardiolipin, PC, PE, PS and PG, from
which cardiolipin, PC, PE and PG are found in both
membrane leaﬂets whereas PS is mainly located in the
cytoplasmic leaﬂet (Gidalevitz et al., 2003; Kurz
et al., 2005; Pomorski et al., 2004; Tannert et al.,
2003).
Our hypothesis is that granulysin binds to
and permeabilizes negatively charged phospholipid
membranes typically found in bacteria but does not
permeabilize target cell membranes when bound to
lipid rafts or phospholipid membranes with eukary-
otic lipid compositions. Experiments were performed
to analyze the eﬀect of granulysin on membranes with
prokaryotic and eukaryotic lipid mixtures as well as
on model membranes, which are commonly used to
study the behavior of biological membranes (Bacia
et al., 2004; Giocondi et al., 2004; Jass, Tjarnhage &
Puu, 2000; Tong & McIntosh, 2004). We used
membranes with negative and uncharged phospho-
lipid compositions as well as lipid raft-like mem-
branes. Fluorescence release assays were used to
analyze the activity of granulysin and ultracentrifu-
gation and immunoblotting, to study the binding of
granulysin to membranes with diﬀerent lipid com-
positions. To further investigate the eﬀect of gra-
nulysin on membranes, atomic force microscopy
(AFM) was used to visualize morphological changes
of granulysin-treated membranes.
Our ﬁndings indicate a strong dependence on
membrane lipid composition and cholesterol content
for granulysin-mediated eﬀects against bacterial and
eukaryotic cell membranes.
Materials and Methods
MATERIALS
1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1-pal-
mitoyl-2-oleoyl-sn-glycero-3-phospho-rac-(1-glycerol) (POPG),
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 2-oleoyl-1-
palmitoyl-sn-glycero-3-phosphocholine (POPC), choles-
terol, sphingomyelin from chicken egg yolk (SM) (Sigma-Aldrich,
St. Louis, MO), 1,1¢,2,2¢-tetramyristoyl cardiolipin and Escherichia
coli total lipid extract (Avanti Polar Lipids, Alabaster, AL) were
stored in a chloroform:methanol (2:1) solution. The ﬂuorescent
lipid dye 2-(4,4-diﬂuoro-5-methyl-4-bora-3a,4a-diaza-s-indancene-3-
dodecanoyl)-1-hexadecanoyl-sn-glycero-3-phosphocholinen-b-Bodipy
(PC-b-Bodipy) was purchased from Molecular Probes (Eugene,
OR), and water was obtained from a Millipore (Billerica, MA)
water puriﬁcation system.
EXPRESSION AND PURIFICATION OF RECOMBINANT
GRANULYSIN
Recombinant granulysin and a fragment of human b-actin (actin
fragment) were cloned, expressed and puriﬁed according to
Walch et al. (2005). Brieﬂy, histidine-tagged recombinant pro-
teins were puriﬁed by nickel aﬃnity chromatography (A¨KTA
Prime; Amersham Biosciences, Uppsala, Sweden) using Ni-NTA
agarose (Qiagen, Hilden, Germany). The eluted protein was di-
luted in 6 M guanidine-HCl and renatured in 0.75 M arginine,
0.05 M Tris-HCl (pH 8), 0.05 M KCl, 0.001 M ethylenediamine-
tetraacetic acid (EDTA) and 0.01 M oxidized dithiothreitol
(Sigma-Aldrich) at a 1:10 dilution with constant stirring at 4C
for 48 h and further puriﬁed using Sep-Pac Vac 6cc (1 g) C18
cartridges (Waters, Milford, MA), from where it was eluted
with 100% acetonitrile containing 0.1% triﬂuoroacetic acid and
lyophilized. Protein concentration was determined using a Bio-
Rad (Hercules, CA) protein assay, and purity was estimated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). Activity of recombinant proteins was tested according
to Walch et al. (2005) using Listeria innocua in a turbidimetry
assay.
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EXTRACTION OF MEMBRANE LIPIDS
Membrane lipids were extracted from L. innocua, Hep-2 cells and
human erythrocytes according to the following procedure. Cells
(20 ml erythrocytes from Buﬀy Coat; Blood Bank SRK, Zu¨rich,
Switzerland) and bacteria (1 liter Tryptic Soy Broth [TSB, Becton
Dickinson, Le Pont de Claix, France] culture, optical density
[OD]600 = 0.8) were centrifuged at 500 · g for 10 min at 4C,
resolved in 10 ml sterile water, mixed with 20 ml isopropanol and
incubated with occasional shaking for 1 h at room temperature.
Chloroform (20 ml) was added to the solution, and the mixture
was incubated for another hour at room temperature, followed
by centrifugation at 500 · g for 30 min at 4C. The lipid extract
was mixed with 10 ml chloroform:methanol (2:1) and washed
with 0.2 volumes of 0.05 M KCl. The purity of the lipids was
tested by thin-layer chromatography, and the lipid extracts were
stored at )20C.
PREPARING LARGE UNILAMELLAR VESICLES AND
SUPPORTED LIPID BILAYERS
E. coli, L. innocua, Hep-2 and erythrocyte lipid extracts, as well as
negatively charged phospholipid (POPG:DPPC 1:2, POPG:DOPE
1:2, cardiolipin:DOPE 1:2 and POPG:SM:POPC 1:1:1), uncharged
phospholipid (POPC:DPPC, 1:2) and lipid raft-like lipid mixtures
(POPG:cholesterol:SM 1:1:1, POPG:cholesterol:POPC 1:1:1) were
dissolved in 20 ml chloroform:methanol (2:1, ﬁnal lipid concen-
tration of approximately 0.5 mg/ml) and evaporated to dryness for
5 min at 500 mbar, 15 min at 250 mbar, 60 min at 150 mbar and
180 min at 100 mbar (Rotavapor; Bu¨chi Labortechnik, Flawil,
Switzerland). The dried lipid ﬁlms were rehydrated in buﬀer (0.05 M
Tris-HCl, 0.15 M NaCl and 0.001 M CaCl2, pH 7.2) containing
12.5 lM of the ﬂuorescent probe 8-aminonaphthalene-1,3,6-trisul-
fon acid, disodium salt (ANTS), and 45 lM of the collisional
quencher p-xylene-bis-pyridinium bromide (DPX, Molecular
Probes) by shaking with 220 rpm for 20 min at 47C. For pH-
dependence measurements, the dried lipid ﬁlms were rehydrated in
Pipes buﬀer at pH 5 and pH 7.2 (0.05 M Pipes, 0.15 M NaCl and
0.001 M CaCl2). The liposome suspensions were extruded through a
polycarbonate membrane with a pore diameter of 400 nm (Avestin,
Ottawa, Canada) using a Liposofast extruder (Avestin) at 47C for
formation of large unilamellar vesicles (LUVs), which were puriﬁed
from excess ANTS and DPX using gel ﬁltration chromatogra-
phy (10 desalting Grade [DG], Bio-Rad) and diluted to a ﬁnal lipid
concentration of 0.1–1 mg/ml.
Supported lipid bilayers were formed by depositing 80 ll
LUV suspension onto a freshly cleaved mica surface with an area
of 0.8 cm2. After a 2 h incubation at 37C for formation of patches
of bilayers or at 50C for testing the formation of bilayers with
liquid crystalline and ordered gel phase separation, the specimens
were cooled down to room temperature, gently rinsed with buﬀer
and analyzed by AFM or confocal laser scanning microscopy.
FLUORESCENCE RELEASE ASSAYS
Granulysin was incubated at various concentrations with LUV in
0.05 M Tris-HCl, 0.15 M NaCl and 0.001 M CaCl2 (pH 7.2) in a
FluoroNunc 96-well plate (Nunc, Roskilde, Denmark). Cloned
actin fragment and buﬀer were used as controls, and 0.1% Triton-X
100 (Sigma-Aldrich) was used for measurement of 100% lysis
(ﬂuorescence release, FR100%). ANTS ﬂuorescence release was
monitored in a DTX-880 multimode detector (Beckman Coulter,
Fullerton, CA) at kexcitation = 370 nm, kemission = 535 nm and the
percentage ﬂuorescence release was calculated using the formula
[(FRgranulysin – FRblank)/(FR100% ) FRblank)] x 100.
ULTRACENTRIFUGATION AND WESTERN BLOT ANALYSIS
LUVs were incubated in buﬀer solution (0.05 M Tris-HCl, 0.15 M
NaCl and 0.001 M CaCl2, pH 7.2) with 5 lM granulysin in a
volume of 400 ll at 37C for 2 h. For some experiments, gra-
nulysin was pretreated with 2,3-butanedione (Sigma-Aldrich),
which covalently modiﬁes the guanidine group of arginine resi-
dues (Walch et al., 2005). After incubation, the LUV solution was
mixed with 1.2 ml 80% (w/v) sucrose solution, overlaid with 1 ml
50% sucrose (w/v) and 1 ml buﬀer solution. Ultracentrifugation
was performed at 140,000 x g for 90 min at 4C. Fractions (6 x
600 ll) were collected from the top and analyzed by Western
blotting (tricine gel, 16.5%) using anti C-terminal-his antibody
(1:5,000; Invitrogen, Carlsbad, CA) and a goat anti-mouse
immunoglobulin G–peroxidase-conjugated antibody (1:5,000,
Sigma-Aldrich). The signal was detected using an enhanced
chemiluminescence Western blotting detection system (Amersham
Biosciences).
AFM
Bilayers were imaged with a Bioscope Multimode AFM (Digital
Instruments, Santa Barbara, CA) in contact mode in buﬀer solu-
tion containing 0.05 M Tris-HCl, 0.15 M NaCl and 0.001 M CaCl2
(pH 7.2) using NanoProbe Si3N4 cantilevers (Digital Instruments).
The force was minimized by adjusting the set point to just under
the jump-oﬀ point of the tip. The scan rate was typically 4–5 Hz.
All images were obtained at room temperature (22C). Images were
analyzed using Nanoscope III (Digital Instruments) or Matlab
(MathWorks, Natick, MA) software.
Supported lipid bilayers with diﬀerent compositions were
imaged with AFM, then treated for 2 h at 37C with granulysin,
cooled down to room temperature, rinsed gently with buﬀer (0.05 M
Tris-HCl, 0.15 M NaCl and 0.001 M CaCl2, pH 7.2) before imaging
again. Real-time imaging could not be performed due to unspeciﬁc
interactions of proteins in solution with the tip. Actin fragment and
buﬀer were used as controls. For temperature stability experiments,
granulysin-treated samples, after imaging with AFM, were heated
to 47C for 30 min, cooled down and imaged again.
The eﬀect of antibody binding was visualized on previ-
ously imaged granulysin-treated bilayers by incubation with an anti
C-terminal-His antibody (1:5,000) on a rocking platform for 1 h at
room temperature, gently rinsed with buﬀer and subsequently im-
aged again.
CONFOCAL LASER MICROSCOPY
The changes in ﬂuidity of PC-b-Bodipy containing negatively
charged phospholipid bilayers were tested at room temperature and
47C, which is over the transition temperature of the lipids, using
ﬂuorescence recovery after photobleaching (FRAP) trials with the
confocal laser scanning microscope (Leica Microsystems, Mann-
heim, Germany).
Results
GRANULYSIN PERMEABILIZES NEGATIVELY CHARGED
CHOLESTEROL-FREE MEMBRANES
To analyze the permeabilization of vesicles by gra-
nulysin, ANTS-loaded LUVs of varying lipid com-
positions were treated with increasing concentrations
of granulysin and the released ANTS ﬂuorescence
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was measured. First, we investigated vesicles
composed of lipid extracts from prokaryotic and
eukaryotic cell membranes. Only the vesicles com-
posed of prokaryotic lipid mixtures were permeabi-
lized by granulysin, whereas vesicles composed of
eukaryotic lipid mixtures were not permeabilized
(Fig. 1A). To compare the eﬀect of granulysin on
diﬀerent lipid mixtures, PG and cardiolipin were used
as negatively charged lipids and PC and PE as un-
charged lipid throughout the following results. As
shown in Figure 1B, LUVs containing negatively
charged phospholipids were eﬀectively permeabilized
by granulysin in contrast to uncharged vesicles. A
50% permeabilization of POPG:DPPC-containing
vesicles was reached at a concentration of 0.15 lM
granulysin, cardiolipin:DOPE-containing vesicles at
0.63 lM of granulysin and POPG:DOPE-containing
vesicles at 1.25 lM of granulysin. The actin fragment
used as control could not permeabilize negatively
charged LUVs.
To investigate the eﬀect of granulysin on
eukaryote-like vesicles, we tested the membranoly-
sing eﬀect of granulysin on cholesterol-containing
lipid raft-like vesicles (POPG:cholesterol:SM). The
results showed no permeabilizing of the cholesterol-
containing vesicles. We also examined which of
the membrane components prevented the membran-
olysing eﬀect of granulysin, using vesicles containing
phospholipids and cholesterol (POPG:cholesterol:POPC)
or sphingomyelin (POPG:SM:POPC). Only choles-
terol-free vesicles were permeabilized by granulysin.
A 50% permeabilization of POPG:SM:POPC was
reached at a granulysin concentration of 0.6 lM,
whereas the cholesterol-containing vesicles were
never permeabilized (Fig. 1C).
To further strengthen the assumption that char-
ges are responsible for permeabilization of LUVs, the
pH dependence of granulysin-induced ﬂuorescence
release was studied. Negatively charged phospholipid
LUVs were treated with diﬀerent concentrations of
granulysin at pH 5 and 7.2. We found that granulysin-
induced ﬂuorescence release was more eﬃcient at
acidic than at neutral pH (Fig. 1D). A ﬂuorescence
release of 50% was reached with 0.02 lM granulysin at
pH 5, much lower than the 0.15 lM measured at pH
7.2. This higher activity correlates with the increased
positive charge of the molecule at lower pH. In con-
trast, granulysin was not able to permeabilize lipid
raft-like LUVs (POPG:cholesterol:SM) even at pH 5.
GRANULYSIN BINDS TO NEGATIVELY CHARGED AND
LIPID RAFT-LIKE MEMBRANES
Since granulysin was able to permeabilize vesicles
composed of prokaryotic lipid compositions and
negatively charged cholesterol-free vesicles, but not
A B
C D
Fig. 1. Fluorescence release assays showing granulysin-induced eﬀects on membranes with (A) E. coli (-n-), L. innocua (-h-), erythrocyte
(-m-) and Hep-2 (-s-) lipid mixtures and on (B) POPG:DPPC (-n-), cardiolipin:DOPE (-*-), POPG:DOPE (-d-) and uncharged
POPC:DPPC (-s-) phospholipid LUVs. Negatively charged LUVs treated with actin fragment (-m-) served as controls. (C) Granulysin-
induced permeabilization on DPPC:POPG (-n-), lipid raft-like POPG:cholesterol:SM (-s-), POPG:SM:POPC (-D-) and POPG:choles-
terol:POPC (-m-). (D) Eﬀect of pH on granulysin-induced permeabilization of lipid raft-like LUVs at pH 5 (-s-) and pH 7.2 (-m-) and of
negatively charged phospholipid LUVs at pH 5 (-D-) and pH 7.2 (-n-). One representative experiment out of three is shown.
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membranes with eukaryotic lipid compositions and
lipid raft-like vesicles (cholesterol-containing), bind-
ing of granulysin to vesicles with diﬀerent composi-
tions was studied. To this end, granulysin-treated
LUVs were analyzed by ultracentrifugation and
Western blotting. Interestingly, granulysin did not
bind only to LUVs exhibiting distinct ﬂuorescence
release but to all LUVs containing negatively charged
lipids, including lipid raft-like LUVs and LUVs
composed of eukaryotic lipid mixtures (Fig. 2).
Granulysin bound to LUVs was located in low-den-
sity fractions (fractions 1–2) and free granulysin in
high-density fractions (fractions 4–6).
To study the importance of arginine residues for
membrane binding, granulysin was pretreated with
2,3-butanedione (BAD) to block positively charged
arginine residues. We found that BAD treatment
abolished the binding of granulysin to negatively
charged LUVs (Fig. 2H), supporting previous
observations (Walch et al., 2005).
GRANULYSIN INDUCED DEFECTS ON SUPPORTED LIPID
BILAYERS
Due to the fact that granulysin binds to negatively
charged phospholipid and all lipid raft-like LUVs but
permeabilizes only negatively charged cholesterol-
free LUVs, we visualized the granulysin-induced
changes in supported lipid bilayers using AFM.
LUVs were attached on mica, where they formed
bilayers with irregularly shaped borders (Fig. 3) and
diameters varying between 0.3 and 3 lm. The height
of the bilayers was 4.5 ± 1 nm in accordance with
the thickness of cell membranes (Chamberlain &
Bowie, 2004). Domain separations could be visual-
ized by AFM only in samples prepared over the
transition temperatures for the lipids, at 50C (data
not shown). However, to obtain more contrast in the
images by visualizing also the mica surface and not
only the phospholipid bilayers, we prepared the
samples at 37C. This procedure oﬀered the possi-
bility to compare the heights of bilayers to those of
the defects.
Untreated (Fig. 3A, C, E, H, J, L) and 5 lM
granulysin-treated (Fig. 3B, D, F, I, K, M) lipid
extract supported bilayers of various compositions
were imaged by AFM. In prokaryotic and negatively
charged phospholipid bilayers, distinct membrane
defects were detected after treatment with granulysin
(Fig. 3B, F, I). The depth of these defects was
5 ± 1 nm, indicating that they penetrated the entire
bilayer. Untreated or actin fragment-treated nega-
tively charged phospholipid bilayers never showed
any defects (Fig. 3E, G). The bilayers composed of
erythrocyte lipids and the cholesterol-containing lipid
raft-like bilayers also showed no defects after treat-
ment with granulysin (Fig. 3K, M).
Supported lipid bilayers incubated with granuly-
sin were compared to granulysin-incubated LUVs
after ultracentrifugation to examine if the defects
were as well formed in bilayers of LUVs in suspen-
sion. After ultracentrifugation, granulysin-incubated
LUVs formed supported bilayers on mica, showing
the same irregularly shaped defects as before and only
on cholesterol-free bilayers with negative charges
(data not shown).
The concentration dependence of granulysin-in-
duced defects was analyzed by AFM imaging of
bilayers after incubation with 1 and 5 lM granulysin.
The number of defects was counted on a represen-
tative area of 25 lm2, and their diameters were
measured using Nanoscope III software. The data
were arbitrarily grouped in four size catego-
ries: £ 40, 41–80, 81–120 and ‡ 121 nm. Data are
shown for defects on negatively charged phospholipid
bilayers (POPG:DPPC and POPG:SM:POPC) in
Figure 4. At a granulysin concentration of 5 lM, a
higher percentage of defects were either 81–120 nm or
larger than 121 nm when compared with defects on
bilayers treated with 1 lM granulysin. These data
indicate a distinct correlation between the concen-
tration of granulysin and the size of the defects in
supported bilayers.
Fig. 2. Binding of granulysin (5 lM) to (A) LUVs composed of
E. coli lipid extracts, (B) erythrocyte lipid extracts, (C)
POPG:DPPC, (D) POPG:SM:POPC, (E) lipid raft-like
POPG:cholesterol:SM, (F) POPG:cholesterol and (G) uncharged
POPC:DPPC. (H) Binding of BAD-treated granulysin to nega-
tively charged phospholipid LUVs. Binding was analyzed by ul-
tracentrifugation and Western blotting. Fractions 1 and 2 contain
LUVs with bound (A-F) or without (G, H) bound granulysin, and
the unbound granulysin is in fractions 4, 5 and 6. The abbreviation
G stands for recombinant granulysin without LUVs as a control.
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Fig. 3. AFM images of supported bilayers on mica, with a corresponding trace along the white line indicating the height images. Results
show untreated (A) and 5 lM granulysin-treated bilayers composed of (B) E. coli lipid mixtures and untreated (C) and 5 lM granulysin-
treated (D) erythrocyte lipid mixtures, (E) untreated, (F) 5 lM granulysin-treated and (G) 5 lM actin fragment-treated POPG:DPPC
bilayers. (H) Untreated and (I) 5 lM granulysin-treated POPG:SM:POPC bilayers; (J, K) untreated and 5 lM granulysin-treated lipid raft-
like POPG:cholesterol:SM bilayers, respectively; (L, M) untreated and 5 lM granulysin-treated POPG:cholesterol:POPC bilayers, respec-
tively. Size of images: 2 x 2 lm, z-scale 15 nm.
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PERSISTENCE OF GRANULYSIN-MEDIATED DEFECTS
To test if granulysin-induced defects remain stable
above the transition temperature of the lipids, FRAP
experiments using confocal laser scanning micros-
copy at room temperature (Fig. 5A) and at 47C
(Fig. 5B) were performed. The result conﬁrmed a
higher recovery rate at higher membrane ﬂuidity at
47C. The persistence of granulysin-induced defects
during higher membrane ﬂuidity was tested on un-
treated negatively charged phospholipid bilayers
(Fig. 5C) and on negatively charged phospholipid
bilayers with granulysin-induced defects (Fig. 5D),
which were heated to 47C for 30 min and imaged
again after cooling to room temperature by AFM
(Fig. 5E, F). The results showed that the defects were
still visible after the membrane was heated to over the
transition temperature of the lipids (Fig. 5F).
Further evidence for the continuous and stable
presence of granulysin was obtained by treatment of
negatively charged phospholipid bilayers with gra-
nulysin and subsequently with anti-His-tag antibody.
In granulysin-treated bilayers, the typical defects were
visible (Fig. 6A). Following incubation with anti-His-
tag antibody, the defects were no longer detectable.
Instead, aggregates with a diameter of 20–120 nm and
a height of 1.5 ± 0.5 nm were found (Fig. 6B). In
untreated control specimens, the surface of the bilay-
ers remained smooth also after antibody incubation
(Fig. 6C).
Discussion
In spite of the growing interest in antimicrobial
proteins and their interactions with membranes, the
structure-related function and mechanism involved in
the contact between granulysin and prokaryotic
vs. eukaryotic cell membranes remains unclear.
Recently, we showed that granulysin destroys intra-
cellular bacteria, such as L. innocua, after binding to
and uptake via lipid rafts by the target cell (Walch et
al., 2005). This mechanism ensures that no premature
killing of the infected cell occurs with resulting release
and further spreading of intracellular bacteria.
To this end, granulysin must interact diﬀerently
with eukaryotic vs. prokaryotic cell membranes.
These membranes diﬀer in their physical and chemi-
cal properties. The major membrane components of
prokaryotic cells are phospholipids, and their mem-
branes contain higher amounts of anionic lipids than
eukaryotic cell membranes but no cholesterol or SM
(Gidalevitz et al., 2003; Huijbregts, de Kroon &
de Kruijﬀ, 2000; Simons & Ikonen, 1997; Simons
& Vaz, 2004; Slotte, 1999; Tannert et al., 2003).
This seems to be of fundamental importance for the
membrane interaction, activity and selectivity of
antimicrobial peptides, as we could show for gra-
nulysin in the present study. The behavior of gra-
nulysin, when coming in contact with eukaryote- and
prokaryote-like membranes, was mirrored by the use
of cell or bacterial lipid extracts. The model mem-
branes consisted of phospholipids and sterols. They
were chosen for their biological interest of being a
component of the eukaryotic or prokaryotic mem-
brane or for their ability to stabilize the model system
and simplify imaging. Our experiments on LUVs
revealed that granulysin binds to cholesterol-con-
taining membranes, generally found in eukaryotic
membranes, but is not able to permeabilize them,
conﬁrming the observation made on infected cells
(Walch et al., 2005), whereas granulysin is able to
bind and permeabilize prokaryotic membranes, as we
showed for E. coli and L. innocua membranes, and
BA
Fig. 4. Concentration
dependence of granulysin-
induced defects. The number
of defects was calculated and
the size measured on an area
of 25 lm2 of 1 lM (open
bars) and 5 lM (solid bars)
granulysin-treated bilayers
from AFM images. The
defects were classiﬁed into
groups according to
size: £ 40, 41–80, 81–120
and ‡121 nm. The results
are shown for negatively
charged phospholipid
bilayers with (A)
POPG:DPPC and (B)
POPG:SM:POPC lipid
mixtures.
H. Barman et al.: Cholesterol Modulates Granulysin Eﬀects 35
cholesterol-free negatively charged phospholipid
model membranes. Our results regarding the activity
of granulysin against prokaryotic membranes are
in agreement with a recent study by Ramamoorthy
et al. (2006). They showed that a granulysin-derived
peptide, G15, is able to bind and disrupt E. coli
outer membranes. They also demonstrated that
G15 is not able to bind to cholesterol-containing
(POPC:POPG:cholesterol) membranes. We could
show that recombinant granulysin binds to all nega-
tively charged membranes, as well as cholesterol-
containing lipid raft-like membranes, typically found
in eukaryotes. This indicates that other domains must
be responsible for binding to cholesterol-containing
negatively charged membranes.
The essential components in the formation of
lipid rafts are cholesterol and SM (Simons & Ikonen,
1997), which form a hydrogen bond between the 3b-
OH group of cholesterol and the amide group of SM.
This hydrogen bond is responsible for the tight
packing of lipid rafts but still ensures a high degree of
lipid mobility (Brown, 1998; Mombelli et al., 2003).
The tight packing in liquid ordered phase of lipid
rafts can additionally be formed between cholesterol
and phospholipids (Ohtake, Schebor & de Pablo,
2006). The acyl chains between the phospholipids are
held together by van der Waals interactions, which
are considerably weaker than hydrogen bonds and,
therefore, responsible for a less tight membrane
packing of prokaryotic membranes and non-lipid
raft parts on the eukaryotic cell membrane (Niu &
A
C D
FE
B
Fig. 5. The level of ﬂuidity of phospholipid membranes was tested
by incorporating a ﬂuorescent dye (PC–b–Bodipy) into the bilayer
and performing FRAP experiments using confocal laser scanning
microscopy. (A, B) Fluorescence recovery compared to a control
area at room temperature and at 47C, respectively. Persistence of
the granulysin-induced defects was tested by imaging (C) untreated
and (D) 5 lM granulysin-treated negatively charged phospholipid
bilayers and then heating the (E) untreated and (F) treated bilayers
over the transition temperature (47C) before imaging again in
AFM. Size of images: 2 x 2 lm, z-scale 15 nm.
A
B
C
Fig. 6. Detection of granulysin binding with anti-His-tag antibody.
Supported negatively charged phospholipid bilayers were incu-
bated with 5 lM granulysin and imaged via AFM showing typical
defects (A). The specimens which were subsequently incubated
with anti-His-tag antibody displayed various aggregates of
1.5 ± 0.5 nm height (B). The surface of untreated bilayers
remained smooth after antibody incubation (C). Size of images:
2 x 2 lm, z-scale 15 nm.
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Litman, 2002), which contain less cholesterol than
lipid rafts (Arispe & Doh, 2002).
We also found that granulysin is more active
in permeabilizing negatively charged phospholipid
LUVs at lower pH values and that BAD-treated
granulysin, due to the modiﬁed arginine residues,
cannot bind to negatively charged vesicles, in agree-
ment with the diﬀerent positive charge of the protein
at various pH values. At neutral pH granulysin has a
net charge of 8, whereas at pH 5 the net charge is 10.
Hanson et al. (1999) showed previously, using ﬂuo-
rescence release assays, that granulysin acts in a
pH-dependent manner; but, in contrast to our results,
they found that granulysin is less active at lower pH
values. Our data indicate that the protection from
lysis of granula may stem from the lipid composition
of the membrane; therefore, we suggest this to be part
of a mechanism for inhibiting the permeabilization of
granules by granulysin. In addition, the pH-depen-
dent activity might have a function in modulating the
activity of granulysin in early and late endosomes, as
well as in lysosomes and phagolysosomes, all deﬁned
stages of endocytosis. The pH in these compartments
changes from 5.9–6.0 in early endosomes to 5.0–6.0 in
late endosomes to 5.0 in lysosomes (Geisow & Evans,
1984; Renswoude et al., 1982). These diﬀerent pH
values could convert granulysin from a less active to a
highly active protein at low pH in the later stages of
endocytosis, further promoting binding to and killing
of intracellular pathogens. It is interesting to note
that traﬃcking of intracellular bacteria in the host
cell, e.g., L. innocua, is along the same route, namely
from endosomes via phagosomes to phagolysosomes,
where it can be eﬃciently lysed by granulysin (Gail-
lard et al., 1987). In the same endocytic pathway,
in the phagosomes, M. tuberculosis can be killed
(Armstrong & Hart, 1971).
The permeabilization of bacterial membranes
after binding of granulysin is supposed to originate
from oligomerization of the protein. Similar to other
cationic proteins of the SAPLIP family, the three-
dimensional structure of granulysin does not allow
the prediction of a pore (Anderson et al., 2003).
Anderson et al. (2003) propose a model for the
mechanism of action for granulysin. After oligomer-
ization, friction between granulysin molecules results
in cooperative membrane lysis and each granulysin
molecule binds to its neighboring molecules, applying
local forces to a part of the membrane. This model
correlates with the carpet model, where, ﬁrst, protein
molecules cover the infected cell by binding to the
membrane using electrostatic interactions and, sec-
ond, permeabilization of the membrane is induced
only where the protein concentration is high enough
(Anderson et al., 2003; Pouny et al., 1992; Shai,
1999).
These model predictions are in agreement with
our results. Granulysin induces defects on choles-
terol-free membranes in a concentration-dependent
manner, which is in accordance with the oligomeri-
zation of the protein bound to the bacterial mem-
brane. This is further supported by the observation of
the nonhomogeneous binding of His-tag antibodies
to granulysin-treated membranes. Binding of the
antibody also proves that granulysin stays attached
to the membrane after causing defects. Furthermore,
higher membrane ﬂuidity, as shown by varying the
temperature, does not lead to granulysin dissociation
from the membranes. The observed persistence of
granulysin-induced defects during transient ﬂuidity
changes over the transition temperatures of the lipids
suggests stable protein-protein and/or protein-lipid
interactions causing the defects to stay permanently.
In conclusion, our study showed that the com-
position and the physical properties of the membrane
are important for granulysin to interact with infected
eukaryotic host cells without aﬀecting the viability of
the cell. The cholesterol content of the host cell
membrane plays a particularly important role in the
potential of granulysin to perturb the membrane. Not
only lipid rafts but also nonraft parts of the eukary-
otic membrane contain cholesterol and can therefore
not be permeabilized, whereas granulysin is able to
bind to lipid rafts from where the protein is taken
up via endocytosis. The cholesterol-free composition
of the prokaryotic membrane is crucial for the
interaction of granulysin with intracellular patho-
gens, leading to permeabilization and ﬁnally lysis of
the bacteria. This provides important information for
understanding the function and mechanism of action
of granulysin and other positively charged antimi-
crobial proteins and how they interact with eukary-
otic and prokaryotic cell membranes.
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